North America Biopharmaceutical Third-Party Logistics Market Size & Outlook
Global Market
Related Markets
North America biopharmaceutical third-party logistics market highlights
- The North America biopharmaceutical third-party logistics market generated a revenue of USD 63,361.4 million in 2025.
- The market is expected to grow at a CAGR of 7.84% from 2026 to 2033.
- In terms of segment, non-cold chain logistics was the largest revenue generating supplychain in 2025.
- Cold Chain Logistics is the most lucrative supplychain segment registering the fastest growth during the forecast period.
- Country-wise, U.S. is expected to register the highest CAGR from 2026 to 2033.
North America data book summary
| Market revenue in 2025 | USD 63,361.4 million |
| Market revenue in 2033 | USD 115,099.3 million |
| Growth rate | 7.84% (CAGR from 2026 to 2033) |
| Largest segment | Non-cold chain logistics |
| Fastest growing segment | Cold Chain Logistics |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Non-cold Chain Logistics, Cold Chain Logistics |
| Key market players worldwide | DHL Group, SF Express, United Parcel Service Inc Class B, AmerisourceBergen Drug Corporation, DB Schenker, Kuehne + Nagel International AG, Kerry Logistics Network Ltd, Agility |
Other key industry trends
- In terms of revenue, North America region accounted for 41.7% of the global biopharmaceutical third-party logistics market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 48,503.5 million by 2033.
North America is the largest market by region in the biopharmaceutical third party logistics market. North America biopharmaceutical third-party logistics market accounted for 41.5% of the global market in 2020.
The North American region comprises of the U.S. and Canada. The largest market share can be attributed to huge biopharmaceutical R&D investments coupled with strong logistic performance index in the region.
No credit card required*
Publish Date: Aug 05, 2026
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Biopharmaceutical Third-Party Logistics Market Scope
Biopharmaceutical Third-Party Logistics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| DHL Group | View profile | 594,396 | Platz der Deutschen Post, Bonn, NW, Germany, 53250 | www.dpdhl.com |
| United Parcel Service Inc Class B | View profile | 500,000 | 55 Glenlake Parkway, N.E. Atlanta, Atlanta, GA, United States, 30328 | www.ups.com |
| Kerry Logistics Network Ltd | View profile | 33,100 | 55 Wing Kei Road, 16th Floor, Kerry Cargo Centre, New Territories, Kwai Chung, Hong Kong, Hong Kong, | www.kln.com |
| Kuehne + Nagel International AG | View profile | 93,064 | Dorfstrasse 50, P.O. Box 67, Schindellegi, Switzerland, CH-8834 | www.kuehne-nagel.com |
| AmerisourceBergen Drug Corporation | View profile | 11-50 | Kelayres, Pennsylvania, United States, North America | www.amerisourcebergendrug.com |
| SF Express | View profile | 10001+ | Shenzhen, Guangdong, China, Asia | www.sf-cityrush.com |
| DB Schenker | View profile | 10001+ | Essen, Nordrhein-Westfalen, Germany, Europe | www.dbschenker.com/global |
| Agility | View profile | 10001+ | Singapore, Central Region, Singapore, Asia | www.agility.com |
North America Biopharmaceutical Third-party Logistics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Biopharmaceutical Third-party Logistics Market Outlook will help companies and investors design strategic landscapes.
Non-Cold Chain Logistics was the largest segment with a revenue share of 83.19% in 2025.
Horizon Databook has segmented the North America biopharmaceutical third-party logistics market based on non-cold chain logistics, cold chain logistics covering the revenue growth of each sub-segment from 2021 to 2033.
North America is the largest market by region in the biopharmaceutical third party logistics market. North America biopharmaceutical third-party logistics market accounted for 41.5% of the global market in 2020.
The North American region comprises of the U.S. and Canada. The largest market share can be attributed to huge biopharmaceutical R&D investments coupled with strong logistic performance index in the region.
- North America Biopharmaceutical Third-Party Logistics Market SupplyChain Outlook (Revenue, USD Million , 2021-2033)
- Cold Chain Logistics
- Non-cold Chain Logistics
- North America Biopharmaceutical Third-Party Logistics Market Services Type Outlook (Revenue, USD Million , 2021-2033)
- Transportation
- Warehousing and Storage
- Other Services
Reasons to subscribe to Biopharmaceutical Third-party Logistics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Biopharmaceutical Third-party Logistics Market Outlook databook
- Our clientele includes a mix of Biopharmaceutical Third-party Logistics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America Biopharmaceutical Third-party Logistics Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into North America Biopharmaceutical Third-party Logistics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
North America Biopharmaceutical Third-Party Logistics Market, 2021-2033 (US$M)
North America SupplyChain - Biopharmaceutical Third-party Logistics Market Statistics, 2025 - 2033 (US$M)
